Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cimpress
CMPR
$2.43B
| $73.1M | 0.05% |
2,648,346
-2,633,224
| -50% | -$68.3M |
|
302
Hartford Financial Services
HIG
$39.3B
| $72.6M | 0.05% |
957,593
-893,171
| -48% | -$64.3M |
|
|
ALTR
303
DELISTED
Altair Engineering Inc
ALTR
| $72.4M | 0.05% |
1,592,184
-1,607,840
| -50% | -$75.2M |
|
304
First Interstate BancSystem
FIBK
$3.7B
| $72.4M | 0.05% |
1,872,081
-2,080,467
| -53% | -$88M |
|
305
Brixmor Property Group
BRX
$9.77B
| $72.3M | 0.05% |
3,190,130
+3,083,326
| +2,887% | +$66M |
|
306
CDW
CDW
$18.4B
| $71.9M | 0.05% |
402,602
-917,940
| -70% | -$161M |
|
307
Sun Communities
SUI
$15.3B
| $71.9M | 0.05% |
502,665
-663,605
| -57% | -$90.6M |
|
308
Agree Realty
ADC
$9.74B
| $71.5M | 0.05% |
1,007,537
-430,613
| -30% | -$29.6M |
|
309
Monarch Casino & Resort
MCRI
$2.2B
| $71.2M | 0.05% |
926,318
-1,157,220
| -56% | -$87.5M |
|
310
Harmony Biosciences
HRMY
$2.07B
| $71.2M | 0.05% |
1,292,135
-1,738,071
| -57% | -$95.6M |
|
311
Labcorp
LH
$25.8B
| $70.8M | 0.05% |
350,157
-301,236
| -46% | -$58.9M |
|
312
Rexford Industrial Realty
REXR
$8.64B
| $70.7M | 0.05% |
1,293,717
-1,778,331
| -58% | -$95.9M |
|
313
Helmerich & Payne
HP
$3.31B
| $70.5M | 0.05% |
1,423,216
-1,410,448
| -50% | -$67.1M |
|
314
Glaukos
GKOS
$8.89B
| $68.6M | 0.05% |
1,570,944
-1,591,674
| -50% | -$78.5M |
|
315
Leslie's
LESL
$9.83M
| $67.2M | 0.05% |
275,114
-200,700
| -42% | -$55.8M |
|
316
HealthEquity
HQY
$8.46B
| $67.2M | 0.05% |
1,089,758
-1,518,670
| -58% | -$102M |
|
317
Envista
NVST
$4.39B
| $65.9M | 0.05% |
1,955,912
-2,690,790
| -58% | -$92M |
|
318
Thor Industries
THO
$4.13B
| $65.7M | 0.05% |
869,810
-865,214
| -50% | -$69.5M |
|
319
Warner Music
WMG
$15B
| $65.1M | 0.05% |
1,859,100
-1,594,800
| -46% | -$46.5M |
|
|
FISV
320
Fiserv Inc
FISV
$28.9B
| $63.8M | 0.05% |
631,339
-742,107
| -54% | -$73.9M |
|
321
Biohaven
BHVN
$2.07B
| $63.3M | 0.05% |
4,562,511
+3,537,876
| +345% | +$50M |
|
322
State Street
STT
$50.2B
| $63.3M | 0.05% |
816,222
-866,044
| -51% | -$63.8M |
|
323
BWX Technologies
BWXT
$15.5B
| $63.1M | 0.05% |
1,086,659
-1,605,061
| -60% | -$92.2M |
|
324
Altimmune
ALT
$581M
| $63.1M | 0.05% |
3,833,579
-4,410,049
| -53% | -$49.5M |
|
325
Seres Therapeutics
MCRB
$46.5M
| $63M | 0.05% |
562,415
-553,910
| -50% | -$74.3M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.